08th November 2021 | Pharma Updates
Suven Pharma 2nd Quarter profit rises 31% to Rs 97 crore
Suven Pharma reported a 31% increase in its consolidated net profit to Rs 97 crore for the 2nd Quarter ended on 30th September.
5 people killed in Gujarat-based Pharma unit
Workers died due to suffocation during while cleaning an underground effluent tank at a pharmaceutical unit in Gujarat.
Ocugen seeks FDA approval for Covaxin use among kids
Ocugen had asked FDA for the EUA of Covaxin for people aged between 18- 20.
Divi's Labs posts a 16.71% rise in consolidated net profit
The drug company has reported a net profit of RS 519.59 crore for the 2nd Quarter of this year.
Imports lead medical devices market
Bangladesh’s medical device makers can meet only 4% of the yearly demand while the rest is procured from other countries.
Vaccine demand will remain high: Emcure MD
Emcure Pharma is seeing opportunities in vaccines and biologics, which it planning to launch in new markets.
Lupin brings generic version of Antara in US
Lupin Pharma has launched the generic
version of Fenoflbrate in the strength of
30 mg and 90 mg.